Skip to main content

Table 4 Comparison of the rebleeding and non rebleeding groups

From: Clinical characteristics of Dieulafoy’s lesion in the small bowel diagnosed and treated by double-balloon endoscopy

Patient characteristic

Rebleeding

 

P value

 

Occurred

Not occurred

 

N

8

30

 

Sex

  

0.99

Male

4

15

 

Female

4

15

 

Age, mean ± SD

73 ± 10

70 ± 10

0.542

Comorbidity (Ohmiya Index)

2.6 ± 3.0

2.2 ± 1.3

0.673

Drugs use

   

antithrombotic

  

0.563

Yes

8

25

 

No

0

5

 

NSAIDs

  

0.99

Yes

1

3

 

No

7

27

 

Prior capsule endoscopy

  

0.99

Performed

6

20

 

Not performed

2

10

 

Lowest hemoglobin level

6.2 ± 3.0

5.9 ± 1.1

0.36

(mean ± SD, g/dl)

   

Blood transfusion, units

12.5 ± 6.3

11.2 ± 9.0

0.226

(mean ± SD)

   

Days from Onset to endoscopy

22 ± 17

23 ± 18

0.969

(mean ± SD)

   

First episode of hematochezia

  

0.049

Yes

2

20

 

No

6

10

 

Lesion located in the duodenum or

  

0.708

upper jejunum

   

Yes

5

16

 

No

3

14

 

Number of lesions

  

0.011

1

4

28

 

≥ 2

4

2

 

Angiodysplasia complicated

  

0.999

Yes

3

10

 

No

5

20

 

Diagnosed by the first DBE

  

0.686

Yes

4

19

 

No

4

11

 

Number of used hemoclips

3.5 ± 0.7

2.5 ± 1.7

0.043

Small blood clot on the surface

  

0.563

Yes

0

5

 

No

8

25

 
  1. NSAID, nonsteroidal anti-inflammatory drugs; DBE, double-balloon endoscopy; SD: standard deviation